I provide short-term psychotherapy services that are practical and solution focused. I take a collaborative approach in helping clients make the changes they are seeking. Additionally, I am certified ...

As a bilingual clinician, I bring transparency, honesty, and cultural awareness to every session. Counseling with me is a collaborative process grounded in respect and accountability. I value your ...

The approval makes Wegovy the first GLP-1 therapy cleared in India for treating adults with non-cirrhotic MASH and ...

In the first of a series of regular columns, Augustine Tanner-Ihm, the senior minister of Wesley Community Church, comments ...

I've previously defined AI-based therapy micro-bursts, which is how people tend to use AI for mental health advice. Now, here ...

If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to treat HAE attacksNDA includes positive data from successful clinical program demonstrating rapid relief and ...

Patients with no other options are watching an agency turn on its own scientists — and the trust that took a century to build ...

Hello everyone, this is Health Brief. We’re almost done with this week, so what’s one thing on deck for next week? The Senate ...

From overcoming classical optical limits to tracking single proteins in real time, super-resolution imaging continues to ...

FDA approved veligrotug-vvze for TED regardless of activity or duration, using a 12-week course of five IV infusions administered every three weeks. Pivotal THRIVE/THRIVE-2 trials met primary and all ...

Brain abscesses located deep within the brain can rapidly become life-threatening and are often difficult to treat through conventional surgery.

The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED).